These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30518936)

  • 21. Inhibition of novel GCN5-ATM axis restricts the onset of acquired drug resistance in leukemia.
    Salunkhe S; Mishra SV; Nair J; Ghosh S; Choudhary N; Kaur E; Shah S; Patkar K; Anand D; Khattry N; Hasan SK; Dutt S
    Int J Cancer; 2018 May; 142(10):2175-2185. PubMed ID: 29297932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted delivery of vitamin D3-loaded nanoparticles to C6 glioma cell line increased resistance to doxorubicin, epirubicin, and docetaxel in vitro.
    Maleklou N; Allameh A; Kazemi B
    In Vitro Cell Dev Biol Anim; 2016 Dec; 52(10):989-1000. PubMed ID: 27503515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical mechanism of acetylsalicylic acid (Aspirin) selective toxicity toward melanoma cell lines.
    Vad NM; Yount G; Moridani MY
    Melanoma Res; 2008 Dec; 18(6):386-99. PubMed ID: 18971789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of DNA damage response and induction of apoptosis mediates synergism between doxorubicin and a new imidazopyridine derivative in breast and lung cancer cells.
    El-Awady RA; Semreen MH; Saber-Ayad MM; Cyprian F; Menon V; Al-Tel TH
    DNA Repair (Amst); 2016 Jan; 37():1-11. PubMed ID: 26590797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicity and Immunogenicity in Murine Melanoma following Exposure to Physical Plasma-Derived Oxidants.
    Bekeschus S; Rödder K; Fregin B; Otto O; Lippert M; Weltmann KD; Wende K; Schmidt A; Gandhirajan RK
    Oxid Med Cell Longev; 2017; 2017():4396467. PubMed ID: 28761621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ATM kinase inhibitor KU-55933 provides neuroprotection against hydrogen peroxide-induced cell damage via a γH2AX/p-p53/caspase-3-independent mechanism: Inhibition of calpain and cathepsin D.
    Chwastek J; Jantas D; Lasoń W
    Int J Biochem Cell Biol; 2017 Jun; 87():38-53. PubMed ID: 28341201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chk1 and Wee1 control genotoxic-stress induced G2-M arrest in melanoma cells.
    Vera J; Raatz Y; Wolkenhauer O; Kottek T; Bhattacharya A; Simon JC; Kunz M
    Cell Signal; 2015 May; 27(5):951-60. PubMed ID: 25683911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of STAT3 phosphorylation enhances tumoricidal effect of IL-15-activated dendritic cell against doxorubicin-resistant lymphoma and leukemia via TNF-α.
    Hira SK; Mondal I; Bhattacharya D; Gupta KK; Manna PP
    Int J Biochem Cell Biol; 2015 Oct; 67():1-13. PubMed ID: 26255115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Derma roller® microneedles-mediated transdermal delivery of doxorubicin and celecoxib co-loaded liposomes for enhancing the anticancer effect.
    Ahmed KS; Shan X; Mao J; Qiu L; Chen J
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1448-1458. PubMed ID: 30889679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of Gas Plasma and Radiotherapy Has Immunostimulatory Potential and Additive Toxicity in Murine Melanoma Cells in Vitro.
    Pasqual-Melo G; Sagwal SK; Freund E; Gandhirajan RK; Frey B; von Woedtke T; Gaipl U; Bekeschus S
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32085661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic growth inhibition based on small-molecule p53 activation as treatment for intraocular melanoma.
    de Lange J; Ly LV; Lodder K; Verlaan-de Vries M; Teunisse AF; Jager MJ; Jochemsen AG
    Oncogene; 2012 Mar; 31(9):1105-16. PubMed ID: 21765463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines.
    Xiao J; Egger ME; McMasters KM; Hao H
    BMC Cancer; 2018 Jun; 18(1):675. PubMed ID: 29929490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ΔNp73 regulates the expression of the multidrug-resistance genes ABCB1 and ABCB5 in breast cancer and melanoma cells - a short report.
    Sakil HAM; Stantic M; Wolfsberger J; Brage SE; Hansson J; Wilhelm MT
    Cell Oncol (Dordr); 2017 Dec; 40(6):631-638. PubMed ID: 28677036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PD-1 Blockade for Improving the Antitumor Efficiency of Polymer-Doxorubicin Nanoprodrug.
    Gao F; Zhang C; Qiu WX; Dong X; Zheng DW; Wu W; Zhang XZ
    Small; 2018 Sep; 14(37):e1802403. PubMed ID: 30129176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
    Stein U; Walther W; Shoemaker RH
    J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-thermal atmospheric pressure plasma induces apoptosis in oral cavity squamous cell carcinoma: Involvement of DNA-damage-triggering sub-G(1) arrest via the ATM/p53 pathway.
    Chang JW; Kang SU; Shin YS; Kim KI; Seo SJ; Yang SS; Lee JS; Moon E; Baek SJ; Lee K; Kim CH
    Arch Biochem Biophys; 2014 Mar; 545():133-40. PubMed ID: 24486404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Organic cation transporter OCT6 mediates cisplatin uptake and resistance to cisplatin in lung cancer.
    Kunii E; Oguri T; Kasai D; Ozasa H; Uemura T; Takakuwa O; Ohkubo H; Takemura M; Maeno K; Niimi A
    Cancer Chemother Pharmacol; 2015 May; 75(5):985-91. PubMed ID: 25772757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair.
    Barckhausen C; Roos WP; Naumann SC; Kaina B
    Oncogene; 2014 Apr; 33(15):1964-74. PubMed ID: 23604128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells.
    Deng S; Yan T; Nikolova T; Fuhrmann D; Nemecek A; Gödtel-Armbrust U; Kaina B; Wojnowski L
    Br J Pharmacol; 2015 May; 172(9):2246-57. PubMed ID: 25521189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alteration of gene expression in melanoma cells following combined treatment with E2F-1 and doxorubicin.
    Hao H; Dong YB; Bowling MT; Zhou HS; McMasters KM
    Anticancer Res; 2006; 26(3A):1947-56. PubMed ID: 16827129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.